Cystathionine β-synthase mutations: effect of mutation topology on folding and activity†
Corresponding Author
Viktor Kožich
First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Institute of Inherited Metabolic Disorders, Prague, Czech Republic
First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Institute of Inherited Metabolic Disorders, Prague, Czech RepublicSearch for more papers by this authorJitka Sokolová
First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Institute of Inherited Metabolic Disorders, Prague, Czech Republic
Search for more papers by this authorVeronika Klatovská
First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Institute of Inherited Metabolic Disorders, Prague, Czech Republic
Search for more papers by this authorJakub Krijt
First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Institute of Inherited Metabolic Disorders, Prague, Czech Republic
Search for more papers by this authorMiroslav Janošík
First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Institute of Inherited Metabolic Disorders, Prague, Czech Republic
Search for more papers by this authorKarel Jelínek
Faculty of Science, Charles University in Prague, Department of Physical and Macromolecular Chemistry, Prague, Czech Republic
Search for more papers by this authorJan P. Kraus
University of Colorado School of Medicine, Department of Pediatrics, Aurora, Colorado
Search for more papers by this authorCorresponding Author
Viktor Kožich
First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Institute of Inherited Metabolic Disorders, Prague, Czech Republic
First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Institute of Inherited Metabolic Disorders, Prague, Czech RepublicSearch for more papers by this authorJitka Sokolová
First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Institute of Inherited Metabolic Disorders, Prague, Czech Republic
Search for more papers by this authorVeronika Klatovská
First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Institute of Inherited Metabolic Disorders, Prague, Czech Republic
Search for more papers by this authorJakub Krijt
First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Institute of Inherited Metabolic Disorders, Prague, Czech Republic
Search for more papers by this authorMiroslav Janošík
First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Institute of Inherited Metabolic Disorders, Prague, Czech Republic
Search for more papers by this authorKarel Jelínek
Faculty of Science, Charles University in Prague, Department of Physical and Macromolecular Chemistry, Prague, Czech Republic
Search for more papers by this authorJan P. Kraus
University of Colorado School of Medicine, Department of Pediatrics, Aurora, Colorado
Search for more papers by this authorCommunicated by David N. Cooper
Abstract
Misfolding of mutant enzymes may play an important role in the pathogenesis of cystathionine β-synthase (CBS) deficiency. We examined properties of a series of 27 mutant variants, which together represent 70% of known alleles observed in patients with homocystinuria due to CBS deficiency. The median amount of SDS-soluble mutant CBS polypeptides in the pellet after centrifugation of bacterial extracts was increased by 50% compared to the wild type. Moreover, mutants formed on average only 12% of tetramers and their median activity reached only 3% of the wild-type enzyme. In contrast to the wild-type CBS about half of mutants were not activated by S-adenosylmethionine. Expression at 18°C substantially increased the activity of five mutants in parallel with increasing the amounts of tetramers. We further analyzed the role of solvent accessibility of mutants as a determinant of their folding and activity. Buried mutations formed on average less tetramers and exhibited 23 times lower activity than the solvent exposed mutations. In summary, our results show that topology of mutations predicts in part the behavior of mutant CBS, and that misfolding may be an important and frequent pathogenic mechanism in CBS deficiency. Hum Mutat 31:1–11, 2010. © 2010 Wiley-Liss, Inc.
Supporting Information
Additional Supporting Information may be found in the online version of this article
Filename | Description |
---|---|
humu_21273_sm_SupplInfo.pdf224.2 KB | Supporting Information |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- Carra S, Sivilotti M, Chavez Zobel AT, Lambert H, Landry J. 2005. HspB8, a small heat shock protein mutated in human neuromuscular disorders, has in vivo chaperone activity in cultured cells. Hum Mol Genet 14: 1659–1669.
- Chen S, Ito M, Saijo T, Naito E, Kuroda Y. 1999. Molecular genetic analysis of pyridoxine-nonresponsive homocystinuric siblings with different blood methionine levels during the neonatal period. J Med Invest 46: 186–191.
- Chen X, Wang L, Fazlieva R, Kruger WD. 2006. Contrasting behaviors of mutant cystathionine β-synthase enzymes associated with pyridoxine response. Hum Mutat 27: 474–482.
- Dawson PA, Cox AJ, Emmerson BT, Dudman NP, Kraus JP, Gordon RB. 1997. Characterisation of five missense mutations in the cystathionine β-synthase gene from three patients with B6-nonresponsive homocystinuria. Eur J Hum Genet 5: 15–21.
- de Franchis R, Kozich V, McInnes RR, Kraus JP. 1994. Identical genotypes in siblings with different homocystinuric phenotypes: identification of three mutations in cystathionine β-synthase using an improved bacterial expression system. Hum Mol Genet 3: 1103–1108.
- de Franchis R, Kraus E, Kozich V, Sebastio G, Kraus JP. 1999. Four novel mutations in the cystathionine β-synthase gene: effect of a second linked mutation on the severity of the homocystinuric phenotype. Hum Mutat 13: 453–457.
10.1002/(SICI)1098-1004(1999)13:6<453::AID-HUMU4>3.0.CO;2-K CAS PubMed Web of Science® Google Scholar
- Evande R, Blom H, Boers GH, Banerjee R. 2002. Alleviation of intrasteric inhibition by the pathogenic activation domain mutation, D444N, in human cystathionine β-synthase. Biochemistry 41: 11832–11837.
- Ferguson KA. 1964. Starch-gel electrophoresis—application to the classification of pituitary proteins and polypeptides. Metabolism 13(Suppl): 985–1002.
- Gaustadnes M, Ingerslev J, Rutiger N. 1999. Prevalence of congenital homocystinuria in Denmark. N Engl J Med 340: 1513.
- Gaustadnes M, Wilcken B, Oliveriusova J, McGill J, Fletcher J, Kraus JP, Wilcken DE. 2002. The molecular basis of cystathionine β-synthase deficiency in Australian patients: genotype–phenotype correlations and response to treatment. Hum Mutat 20: 117–126.
- Gordon RB, Cox AJ, Dawson PA, Emmerson BT, Kraus JP, Dudman NP. 1998. Mutational analysis of the cystathionine β-synthase gene: a splicing mutation, two missense mutations and an insertion in patients with homocystinuria. Mutations in brief no. 120. Online. Hum Mutat 11:332.
- Gupta S, Wang L, Hua X, Krijt J, Kozich V, Kruger WD. 2008. Cystathionine β-synthase p.S466L mutation causes hyperhomocysteinemia in mice. Hum Mutat 29: 1048–1054.
- Hedrick JL, Smith AJ. 1968. Size and charge isomer separation and estimation of molecular weights of proteins by disc gel electrophoresis. Arch Biochem Biophys 126: 155–164.
- Heil SG, Riksen NP, Boers GH, Smulders Y, Blom HJ. 2007. DNA methylation status is not impaired in treated cystathionine β-synthase (CBS) deficient patients. Mol Genet Metab 91: 55–60.
- Hu FL, Gu Z, Kozich V, Kraus JP, Ramesh V, Shih VE. 1993. Molecular basis of cystathionine β-synthase deficiency in pyridoxine responsive and nonresponsive homocystinuria. Hum Mol Genet 2: 1857–1860.
- Janosik M, Kery V, Gaustadnes M, Maclean KN, Kraus JP. 2001a. Regulation of human cystathionine β-synthase by S-adenosyl-L-methionine: evidence for two catalytically active conformations involving an autoinhibitory domain in the C-terminal region. Biochemistry 40: 10625–10633.
- Janosik M, Oliveriusova J, Janosikova B, Sokolova J, Kraus E, Kraus JP, Kozich V. 2001b. Impaired heme binding and aggregation of mutant cystathionine β-synthase subunits in homocystinuria. Am J Hum Genet 68: 1506–1513.
- Janosik M, Sokolova J, Janosikova B, Krijt J, Klatovska V, Kozich V. 2009. Birth prevalence of homocystinuria in Central Europe: frequency and pathogenicity of mutation c.1105C T (p.R369C) in the cystathionine β-synthase gene. J Pediatr 154: 431–437.
- Katsushima F, Oliveriusova J, Sakamoto O, Ohura T, Kondo Y, Iinuma K, Kraus E, Stouracova R, Kraus JP. 2006. Expression study of mutant cystathionine β-synthase found in Japanese patients with homocystinuria. Mol Genet Metab 87: 323–328.
- Kim CE, Gallagher PM, Guttormsen AB, Refsum H, Ueland PM, Ose L, Folling I, Whitehead AS, Tsai MY, Kruger WD. 1997. Functional modeling of vitamin responsiveness in yeast: a common pyridoxine-responsive cystathionine β-synthase mutation in homocystinuria. Hum Mol Genet 6: 2213–2221.
- Kluijtmans LA, Boers GH, Kraus JP, van den Heuvel LP, Cruysberg JR, Trijbels FJ, Blom H. 1998. The molecular basis of homocystinuria due to cystathionine β-synthase deficiency in Dutch homocystinuria patients. Effect of CBS genotype on biochemical and clinical phenotype, and on response upon treatment. PhD thesis. The Netherlands: University of Nijmegen.
- Kluijtmans LA, Boers GH, Kraus JP, van den Heuvel LP, Cruysberg JR, Trijbels FJ, Blom HJ. 1999. The molecular basis of cystathionine β-synthase deficiency in Dutch patients with homocystinuria: effect of CBS genotype on biochemical and clinical phenotype and on response to treatment. Am J Hum Genet 65: 59–67.
- Kluijtmans LA, Boers GH, Stevens EM, Renier WO, Kraus JP, Trijbels FJ, van den Heuvel LP, Blom HJ. 1996. Defective cystathionine β-synthase regulation by S-adenosylmethionine in a partially pyridoxine responsive homocystinuria patient. J Clin Invest 98: 285–289.
- Kopecka J, Krijt J, Rakova K, Kozich V. In press. Restoring assembly and activity of cystathionine β-synthase mutants by ligands and chemical chaperones. J Inherit Metab Dis. DOI: 10.1007/s10545-010-9087-5.
10.1007/s10545‐010‐9087‐5 Google Scholar
- Kozich V, de Franchis R, Kraus JP. 1993. Molecular defect in a patient with pyridoxine-responsive homocystinuria. Hum Mol Genet 2: 815–816.
- Kozich V, Kraus JP. 1992. Screening for mutations by expressing patient cDNA segments in E. coli: homocystinuria due to cystathionine β-synthase deficiency. Hum Mutat 1: 113–123.
- Kruger WD, Wang L, Jhee KH, Singh RH, Elsas 2nd LJ. 2003. Cystathionine β-synthase deficiency in Georgia: correlation of clinical and biochemical phenotype with genotype. Hum Mutat 22: 434–441.
- Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685.
- Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275.
- Maclean KN, Gaustadnes M, Oliveriusova J, Janosik M, Kraus E, Kozich V, Kery V, Skovby F, Rudiger N, Ingerslev J, and others. 2002. High homocysteine and thrombosis without connective tissue disorders are associated with a novel class of cystathionine β-synthase (CBS) mutations. Hum Mutat 19: 641–655.
- Marble M, Geraghty MT, de Franchis R, Kraus JP, Valle D. 1994. Characterization of a cystathionine β-synthase allele with three mutations in cis in a patient with B6 nonresponsive homocystinuria. Hum Mol Genet 3: 1883–1886.
- Mato JM, Avila MA, Corrales FJ. 2001. Biosynthesis of S-adenosylmethionin. In: R Carmel, DW Jacobsen, editors. Homocysteine in health and disease. Cambridge: Cambridge University Press. p 47–62.
- Meier M, Janosik M, Kery V, Kraus JP, Burkhard P. 2001. Structure of human cystathionine β-synthase: a unique pyridoxal 5′-phosphate-dependent heme protein. EMBO J 20: 3910–3916.
- Meier M, Oliveriusova J, Kraus JP, Burkhard P. 2003. Structural insights into mutations of cystathionine β-synthase. Biochim Biophys Acta 1647: 206–213.
- Mirkovic N, Marti-Renom MA, Weber BL, Sali A, Monteiro AN. 2004. Structure-based assessment of missense mutations in human BRCA1: implications for breast and ovarian cancer predisposition. Cancer Res 64: 3790–3797.
- Mudd SH, Levy HL, Kraus JP. 2001. Disorders of transsulfuration. In: CR Scriver, AL Beaudet, WS Sly, D Valle, editors. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill. p 2007–2056.
- Ojha S, Wu J, LoBrutto R, Banerjee R. 2002. Effects of heme ligand mutations including a pathogenic variant, H65R, on the properties of human cystathionine β-synthase. Biochemistry 41: 4649–4654.
- Orendac M, Pronicka E, Kubalska J, Janosik M, Sokolova J, Linnebank M, Koch HG, Kozich V. 2004. Identification and functional analysis of two novel mutations in the CBS gene in Polish patients with homocystinuria. Hum Mutat 23: 631.
- Orendac M, Zeman J, Stabler SP, Allen RH, Kraus JP, Bodamer O, Stockler-Ipsiroglu S, Kvasnicka J, Kozich V. 2003. Homocystinuria due to cystathionine β-synthase deficiency: novel biochemical findings and treatment efficacy. J Inherit Metab Dis 26: 761–773.
- Proudfoot M, Sanders SA, Singer A, Zhang R, Brown G, Binkowski A, Xu L, Lukin JA, Murzin AG, Joachimiak A, and others. 2008. Biochemical and structural characterization of a novel family of cystathionine β-synthase domain proteins fused to a Zn ribbon-like domain. J Mol Biol 375: 301–315.
- Refsum H, Fredriksen A, Meyer K, Ueland PM, Kase BF. 2004. Birth prevalence of homocystinuria. J Pediatr 144: 830–832.
- Sali A, Blundell TL. 1993. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234: 779–815.
- Sali A, Overington JP. 1994. Derivation of rules for comparative protein modeling from a database of protein structure alignments. Protein Sci 3: 1582–1596.
- Sebastio G, Sperandeo MP, Panico M, de Franchis R, Kraus JP, Andria G. 1995. The molecular basis of homocystinuria due to cystathionine β-synthase deficiency in Italian families, and report of four novel mutations. Am J Hum Genet 56: 1324–1333.
- Sen S, Yu J, Yamanishi M, Schellhorn D, Banerjee R. 2005. Mapping peptides correlated with transmission of intrasteric inhibition and allosteric activation in human cystathionine β-synthase. Biochemistry 44: 14210–14216.
- Shan X, Dunbrack Jr RL, Christopher SA, Kruger WD. 2001. Mutations in the regulatory domain of cystathionine β synthase can functionally suppress patient-derived mutations in cis. Hum Mol Genet 10: 635–643.
- Singh LR, Chen X, Kozich V, Kruger WD. 2007. Chemical chaperone rescue of mutant human cystathionine β-synthase. Mol Genet Metab 91: 335–342.
- Urreizti R, Asteggiano C, Cozar M, Frank N, Vilaseca MA, Grinberg D, Balcells S. 2006. Functional assays testing pathogenicity of 14 cystathionine-β synthase mutations. Hum Mutat 27: 211.
- Wang L, Chen X, Tang B, Hua X, Klein-Szanto A, Kruger WD. 2005. Expression of mutant human cystathionine β-synthase rescues neonatal lethality but not homocystinuria in a mouse model. Hum Mol Genet 14: 2201–2208.
- Waters PJ. 2003. How PAH gene mutations cause hyper-phenylalaninemia and why mechanism matters: insights from in vitro expression. Hum Mutat 21: 357–369.
- Yamanishi M, Kabil O, Sen S, Banerjee R. 2006. Structural insights into pathogenic mutations in heme-dependent cystathionine-β-synthase. J Inorg Biochem 100: 1988–1995.